Some argue that myocardial structural abnormalities caused by RyR2 variants may be due to CPVT rather than the mutated gene that directly causes ACM as its clinical and pathological features do not show a characteristic ACM-like fibrofatty infiltrative changes [48]. Here, RYR2 is linked to catecholaminergic polymorphic ventricular tachycardia.